US Patent 10501516 Peptide compound
Patent 10501516 was granted and assigned to Takeda Pharmaceutical Company on December, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
May 23, 2017
Date of Patent
December 10, 2019
Patent Applicant
Patent Application Number
16303975
Patent Citations
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10501516 Peptide compound
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
